These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 2143806)

  • 1. Domain swapping reveals the modular nature of Fos, Jun, and CREB proteins.
    Ransone LJ; Wamsley P; Morley KL; Verma IM
    Mol Cell Biol; 1990 Sep; 10(9):4565-73. PubMed ID: 2143806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of dimerization and DNA binding functions in Fos and Jun by domain-swapping: involvement of residues outside the leucine zipper/basic region.
    Cohen DR; Curran T
    Oncogene; 1990 Jun; 5(6):929-39. PubMed ID: 2113670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jun DNA-binding is modulated by mutations between the leucines or by direct interaction of fos with the TGACTCA sequence.
    Hirai S; Yaniv M
    New Biol; 1989 Nov; 1(2):181-91. PubMed ID: 2562220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. fos-jun conspiracy: implications for the cell.
    Verma IM; Ransone LJ; Visvader J; Sassone-Corsi P; Lamph WW
    Ciba Found Symp; 1990; 150():128-37; discussion 137-46. PubMed ID: 2115424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation by Fos and Jun in vitro: interaction among multiple activator and regulatory domains.
    Abate C; Luk D; Curran T
    Mol Cell Biol; 1991 Jul; 11(7):3624-32. PubMed ID: 1904542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The basic region of Fos mediates specific DNA binding.
    Nakabeppu Y; Nathans D
    EMBO J; 1989 Dec; 8(12):3833-41. PubMed ID: 2511004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-binding and dimerization domains of adenosine 3',5'- cyclic monophosphate-responsive protein CREB reside in the carboxyl-terminal 66 amino acids.
    Yun YD; Dumoulin M; Habener JF
    Mol Endocrinol; 1990 Jun; 4(6):931-9. PubMed ID: 2146495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein-Barr virus BZLF1 promoter.
    Taylor N; Flemington E; Kolman JL; Baumann RP; Speck SH; Miller G
    J Virol; 1991 Aug; 65(8):4033-41. PubMed ID: 1649314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct cloning of leucine zipper proteins: Jun binds cooperatively to the CRE with CRE-BP1.
    Macgregor PF; Abate C; Curran T
    Oncogene; 1990 Apr; 5(4):451-8. PubMed ID: 2139203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fos, Jun and CREB basic-domain peptides have intrinsic DNA-binding activity enhanced by a novel stabilizing factor.
    Busch SJ; Sassone-Corsi P
    Oncogene; 1990 Oct; 5(10):1549-56. PubMed ID: 2147467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and purification of the leucine zipper and DNA-binding domains of Fos and Jun: both Fos and Jun contact DNA directly.
    Abate C; Luk D; Gentz R; Rauscher FJ; Curran T
    Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1032-6. PubMed ID: 2105492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-talk in signal transduction: TPA-inducible factor jun/AP-1 activates cAMP-responsive enhancer elements.
    Sassone-Corsi P; Ransone LJ; Verma IM
    Oncogene; 1990 Mar; 5(3):427-31. PubMed ID: 2107494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing fos oncoprotein to a jun-independent DNA binding protein with GCN4 dimerization specificity by swapping "leucine zippers".
    Sellers JW; Struhl K
    Nature; 1989 Sep; 341(6237):74-6. PubMed ID: 2505087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. fos-jun Conspiracy: implications for the cell.
    Verma IM; Ransone LJ; Visvader J; Sassone-Corsi P; Lamph WW
    Princess Takamatsu Symp; 1989; 20():119-26. PubMed ID: 2518685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both the basic region and the 'leucine zipper' domain of the cyclic AMP response element binding (CREB) protein are essential for transcriptional activation.
    Dwarki VJ; Montminy M; Verma IM
    EMBO J; 1990 Jan; 9(1):225-32. PubMed ID: 2136830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trans-dominant negative mutants of Fos and Jun.
    Ransone LJ; Visvader J; Wamsley P; Verma IM
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3806-10. PubMed ID: 2111017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse vimentin: structural relationship to fos, jun, CREB and tpr.
    Capetanaki Y; Kuisk I; Rothblum K; Starnes S
    Oncogene; 1990 May; 5(5):645-55. PubMed ID: 2140597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel association of Fos and Jun leucine zippers juxtaposes DNA binding domains.
    Gentz R; Rauscher FJ; Abate C; Curran T
    Science; 1989 Mar; 243(4899):1695-9. PubMed ID: 2494702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C-terminal domain of c-fos is required for activation of an AP-1 site specific for jun-fos heterodimers.
    McBride K; Nemer M
    Mol Cell Biol; 1998 Sep; 18(9):5073-81. PubMed ID: 9710591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterodimer formation between CREB and JUN proteins.
    Benbrook DM; Jones NC
    Oncogene; 1990 Mar; 5(3):295-302. PubMed ID: 2138276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.